ArticleJMIR medical informatics2026

Early Immunological Biomarkers for Personalized Treatment Selection in Severe COVID-19: Post Hoc Machine Learning Analysis of a Randomized Clinical Trial.

Symeon Savvopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.